Suppr超能文献

原发性高血压:20 年的血流动力学及治疗变化

Essential hypertension: hemodynamic and therapeutic changes over 20 years.

作者信息

Lund-Johansen P

机构信息

Section of Cardiology, University of Bergen, Haukeland Hospital, Norway.

出版信息

J Cardiovasc Pharmacol. 1991;18 Suppl 4:S1-7.

PMID:1721971
Abstract

The hemodynamic disturbances in essential hypertension depend on the age of the subjects and the severity of the hypertensive state. In a 20-year follow-up study, we demonstrated a shift in the hemodynamic characteristics from a high output/normal resistance pattern in the early phase toward a low-flow/high-resistance pattern in the later period. The arteriovenous oxygen difference increased, particularly during exercise, and the oxygen reserve in venous blood decreased. Treatment with conventional drugs (beta-blockers and/or diuretics) for 20 years with satisfactory control of diastolic blood pressure did not prevent a marked increase in total peripheral resistance and a reduction in stroke index and cardiac index. In recent years, beta-blockers with vasodilating activity have been introduced in the treatment of hypertension (labetalol, acebutolol, dilevalol, celiprolol, and carvedilol). The hemodynamic effects of these compounds clearly differ from the changes induced during acute and chronic conventional beta-blocking treatment. In contrast to the usual beta-blockers, these drugs reduce total peripheral resistance acutely, and reduce cardiac index considerably less; arteriovenous oxygen difference is more normal. In an acute study of carvedilol in 18 patients with essential hypertension, total peripheral resistance was reduced 8% at rest (supine) and 6% during exercise. Exercise heart rate was reduced 12%, but due to an increase in stroke index, the reduction in cardiac index was only 6%-considerably less than what is seen during treatment with conventional beta-blockers.

摘要

原发性高血压中的血流动力学紊乱取决于受试者的年龄和高血压状态的严重程度。在一项为期20年的随访研究中,我们证明了血流动力学特征从早期的高输出/正常阻力模式向后期的低流量/高阻力模式转变。动静脉氧差增加,尤其是在运动期间,静脉血中的氧储备减少。用传统药物(β受体阻滞剂和/或利尿剂)治疗20年,舒张压得到满意控制,但并不能阻止总外周阻力显著增加以及卒中指数和心脏指数降低。近年来,具有血管舒张活性的β受体阻滞剂已被引入高血压治疗(拉贝洛尔、醋丁洛尔、地来洛尔、塞利洛尔和卡维地洛)。这些化合物的血流动力学效应明显不同于急性和慢性传统β受体阻滞剂治疗期间引起的变化。与常用的β受体阻滞剂不同,这些药物可急性降低总外周阻力,对心脏指数的降低幅度要小得多;动静脉氧差更接近正常。在一项对18例原发性高血压患者进行的卡维地洛急性研究中,静息(仰卧)时总外周阻力降低8%,运动时降低6%。运动心率降低12%,但由于卒中指数增加,心脏指数的降低仅为6%,远低于传统β受体阻滞剂治疗期间的降幅。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验